• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    45 Stocks Moving In Monday's Mid-Day Session

    1/10/22 12:14:44 PM ET
    $AACG
    $ABSI
    $ACY
    $APR
    Other Consumer Services
    Real Estate
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $AACG alert in real time by email

    Gainers

    • Bone Biologics Corporation (NASDAQ:BBLG) shares climbed 71.5% to $5.88.
    • Zynga Inc. (NASDAQ:ZNGA) gained 45.7% to $8.74 after the company announced it will be acquired by Take-Two Interactive Software in a cash and stock transaction valued at $9.86 per Zynga share, representing a total enterprise value of approximately $12.7 billion.
    • Apria, Inc. (NASDAQ:APR) shares climbed 25.1% to $37.17. Owens & Minor agreed to acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion.
    • Pluristem Therapeutics Inc. (NASDAQ:PSTI) gained 22.5% to $1.80. Pluristem Therapeutics and Tnuva Group have collaborated to develop, manufacture and commercialize cultured cell-based products for the food industry.
    • Capstar Special Purpose Acquisition Corp. (NYSE:CPSR) shares rose 19.7% to $11.65.
    • Molecular Partners AG (NASDAQ:MOLN) rose 19.3% to $19.66 after the company, and Novartis, reported topline data from the Phase 2 study for ensovibep, a DARPin antiviral therapeutic for COVID-19.
    • Tilray, Inc. (NASDAQ:TLRY) surged 18.4% to $7.60 after the company announced fiscal second-quarter 2022 financial results showing revenue increased year-over-year and the company reached profitability.
    • BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) gained 17.6% to $13.59 after the company announced preliminary, unaudited ORLADEYO revenue for Q4 and FY21 and provided new guidance for full year 2022 ORLADEYO net revenue and expected peak ORLADEYO sales.
    • Discovery, Inc. (NASDAQ:DISCB) surged 15.7% to $41.02. The company, along with AT&T, recently won a favorable ruling from the Internal Revenue Service for the planned merger between the company and AT&T's WarnerMedia entertainment business.
    • AeroCentury Corp. (NYSE:ACY) jumped 15% to $11.04. AeroCentury, last month, reported a 5-for-1 split.
    • Olink Holding AB (NASDAQ:OLK) surged 14.1% to $13.33. Olink said it sees Q4 sales of $43.2 million to $43.7 million and expects FY21 sales of $94.5 million to $95 million.
    • Lucira Health, Inc. (NASDAQ:LHDX) gained 13.7% to $8.15 after the company issued strong sales forecast for the fourth quarter.
    • Reliance Global Group, Inc. (NASDAQ:RELI) rose 11.2% to $6.78. Reliance Global Group, last month, announced pricing of $20.0 million private placement with institutional investors.
    • Immix Biopharma, Inc. (NASDAQ:IMMX) gained 11% to $5.95.
    • Century Therapeutics, Inc. (NASDAQ:IPSC) surged 10.4% to $14.59. Century Therapeutics and Bristol Myers Squibb have announced a research collaboration and license agreement for up to four induced pluripotent stem cell (iPSC) programs for hematologic malignancies and solid tumors.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) gained 9.7% to $2.4701. McDade Products, LLC joined forces with G Medical Tests and Services to provide U.S. retailers with millions of COVID-19 at-home PCR test kits.
    • CareDx, Inc (NASDAQ:CDNA) shares rose 8.3% to $42.29 after the company issued strong sales forecast.

    Check out these big penny stock gainers and losers

    Losers

    • TDH Holdings, Inc. (NASDAQ:PETZ) shares dipped 67.4% to $1.3301. TDH Holdings, last month, reported H1 revenue of $130,000.
    • Rapid Micro Biosystems, Inc. (NASDAQ:RPID) fell 24.3% to $6.92. Rapid Micro Biosystems said it expects Q4 total revenue of between $4.7 and $5.2 million.
    • Marpai, Inc. (NASDAQ:MRAI) shares declined 22.1% to $2.7450.
    • Kidpik Corp. (NASDAQ:PIK) dropped 21.3% to $5.15. Kidpik, last month, posted a Q3 loss of $0.22 per share.
    • Amicus Therapeutics, Inc. (NASDAQ:FOLD) dipped 19.2% to $9.22. Amicus Therapeutics said it sees FY21 Galafold sales of $306 million.
    • Hour Loop, Inc. (NASDAQ:HOUR) fell 18% to $6.55. The company’s stock jumped around 100% on Friday after the company priced its IPO at $4 per share.
    • Bird Global, Inc. (NYSE:BRDS) dipped 18% to $4.7550.
    • Citi Trends, Inc. (NASDAQ:CTRN) shares declined 17% to $67.32. Citi Trends reported 2021 holiday sales results and updated long-term strategic plan.
    • Cyngn Inc. (NASDAQ:CYN) dropped 16.8% to $3.02. Cyngn said Global Logistics and Fulfillment LLC has engaged the company as its exclusive autonomous vehicle solutions provider.
    • Pixelworks, Inc. (NASDAQ:PXLW) fell 16.4% to $3.4350.
    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) fell 16% to $1.7486.
    • Elite Education Group International Limited (NASDAQ:EEIQ) dropped 16% to $2.4673.
    • Zhangmen Education Inc. (NYSE:ZME) declined 15.6% to $1.8150.
    • CinCor Pharma, Inc. (NASDAQ:CINC) dipped 15.6% to $13.49. The company, on Friday, priced its IPO at $16 per share.
    • Marin Software Incorporated (NASDAQ:MRIN) fell 15% to $3.85. Marin Software shares jumped 31% on Friday after the company announced an integration with Amazon Ads' demand-side platform.
    • PetVivo Holdings, Inc. (NASDAQ:PETV) dropped 15% to $2.55.
    • OneSmart International Education Group Limited (NYSE:ONE) fell 14.5% to $0.2481 after gaining more than 5% on Friday.
    • Take-Two Interactive Software, Inc. (NASDAQ:TTWO) dropped 14.4% to $140.85 after the company announced it will acquire all of the outstanding shares of Zynga in a cash and stock transaction valued at $9.861 per Zynga share, with a total enterprise value of approximately $12.7 billion.
    • GameStop Corp. (NYSE:GME) dropped 14% to $120.94 amid overall market weakness following a rise in yields as well as continued Fed tapering concerns for 2022.
    • Absci Corporation (NASDAQ:ABSI) shares fell 12.5% to $6.29. Absci shares gained 17% on Friday after the company announced a research collaboration with Merck.
    • Bill.com Holdings, Inc. (NYSE:BILL) declined 12% to $177.66 amid a rise in bond yields, which has weighed on growth stock valuations. Bill.com is expected to report Q2 financial results on February 3, 2022
    • ATA Creativity Global (NASDAQ:AACG) fell 11.6% to $2.3350 after jumping more than 33% on Friday.
    • Torrid Holdings Inc. (NYSE:CURV) fell 11.5% to $9.47 after the company lowered its Q4 revenue guidance.
    • Vigil Neuroscience, Inc. (NASDAQ:VIGL) dipped 11.1% to $11.25. The company, on Friday, priced its IPO at $14 per share.
    • Fangdd Network Group Ltd. (NASDAQ:DUO) fell 9.6% to $0.3367. FangDD, on Friday, received Nasdaq notice regarding minimum bid requirements.
    • Arcadia Biosciences, Inc. (NASDAQ:RKDA) shares fell 8.8% to $1.04 after climbing around 12% on Friday.
    • China HGS Real Estate Inc. (NASDAQ:HGSH) fell 8.6% to $3.1801 after jumping over 57% on Friday.
    • Lululemon Athletica Inc. (NASDAQ:LULU) dropped 5.6% to $335.30 after the company issued Q4 adjusted EPS and sales guidance below estimates.
    Get the next $AACG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AACG
    $ABSI
    $ACY
    $APR

    CompanyDatePrice TargetRatingAnalyst
    Immix Biopharma Inc.
    $IMMX
    2/9/2026$14.00Outperform
    Mizuho
    BILL Holdings Inc.
    $BILL
    2/6/2026$50.00 → $46.00Market Perform
    BMO Capital Markets
    Tilray Brands Inc.
    $TLRY
    1/27/2026Hold
    Canaccord Genuity
    Amicus Therapeutics Inc.
    $FOLD
    1/22/2026$14.50Buy → Hold
    Jefferies
    lululemon athletica inc.
    $LULU
    1/8/2026Hold
    Deutsche Bank
    Absci Corporation
    $ABSI
    1/8/2026$4.32Overweight → Equal-Weight
    Morgan Stanley
    CareDx Inc.
    $CDNA
    1/6/2026$26.00Buy → Hold
    Craig Hallum
    Amicus Therapeutics Inc.
    $FOLD
    12/29/2025$14.50Outperform → Market Perform
    Leerink Partners
    More analyst ratings

    $AACG
    $ABSI
    $ACY
    $APR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BILL Reports Second Quarter Fiscal Year 2026 Financial Results

    Q2 Core Revenue Increased 17% Year-Over-Year Q2 Total Revenue Increased 14% Year-Over-Year BILL (NYSE:BILL), the intelligent finance platform trusted by half a million businesses to manage, move and maximize their money, today announced financial results for the second fiscal quarter ended December 31, 2025. "We delivered a strong Q2, with a significant beat on revenue and profitability, and continued our track record of rapid innovation," said René Lacerte, BILL CEO and Founder. "With a leading position in a large market, strong brand recognition, and a differentiated platform and distribution ecosystem, we are leveraging our unique assets alongside AI to eliminate unnecessary wor

    2/5/26 4:01:00 PM ET
    $BILL
    EDP Services
    Technology

    Pixelworks Appoints Sevan Brown to Lead Business Development for TrueCut Motion

    20-Year Media and Entertainment Executive to Drive Expanded Partnerships and Industry Adoption of TrueCut Motion™ Platform LOS ANGELES, Feb. 5, 2026 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ:PXLW) ("Pixelworks" or the "Company"), a provider of innovative cinematic and enhanced visualization solutions, today announced the appointment of Sevan Brown as Executive Vice President of Business Development. In the newly created role, Brown will lead the Company's enhanced focus on securing and growing global business partnerships for its TrueCut Motion platform with major Hollywood studios, international exhibitors and streaming service providers. Most recently, Brown served as Senior Vice President

    2/5/26 8:00:00 AM ET
    $PXLW
    Semiconductors
    Technology

    Cyngn Advances Site-Wide Autonomy With DriveMod Tugger Operations Across Connected Facilities

    MOUNTAIN VIEW, Calif., Feb. 5, 2026 /PRNewswire/ -- Cyngn Inc. (NASDAQ:CYN) today highlighted continued expansion of DriveMod Tugger deployments across large, connected industrial facilities, reflecting growing customer demand for site-wide autonomy that supports end-to-end material movement. DriveMod is increasingly being used in workflows that span multiple buildings and outdoor transit corridors, helping organizations reduce bottlenecks, improve throughput consistency, and redeploy labor toward higher-value operations. As warehouses and manufacturing campuses grow larger—of

    2/5/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    $AACG
    $ABSI
    $ACY
    $APR
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by CareDx Inc.

    SCHEDULE 13G - CareDx, Inc. (0001217234) (Subject)

    2/9/26 6:23:49 AM ET
    $CDNA
    Medical Specialities
    Health Care

    SEC Form SCHEDULE 13G filed by BioCryst Pharmaceuticals Inc.

    SCHEDULE 13G - BIOCRYST PHARMACEUTICALS INC (0000882796) (Subject)

    2/9/26 6:19:43 AM ET
    $BCRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Arcadia Biosciences Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Arcadia Biosciences, Inc. (0001469443) (Filer)

    2/6/26 4:03:58 PM ET
    $RKDA
    Farming/Seeds/Milling
    Consumer Staples

    $AACG
    $ABSI
    $ACY
    $APR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mizuho initiated coverage on Immix Biopharma with a new price target

    Mizuho initiated coverage of Immix Biopharma with a rating of Outperform and set a new price target of $14.00

    2/9/26 7:01:42 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BMO Capital Markets reiterated coverage on Bill.com with a new price target

    BMO Capital Markets reiterated coverage of Bill.com with a rating of Market Perform and set a new price target of $46.00 from $50.00 previously

    2/6/26 6:48:02 AM ET
    $BILL
    EDP Services
    Technology

    Canaccord Genuity initiated coverage on Tilray

    Canaccord Genuity initiated coverage of Tilray with a rating of Hold

    1/27/26 9:29:20 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $AACG
    $ABSI
    $ACY
    $APR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    President, CEO and Chairman Cohen Ryan bought $21,359,200 worth of shares (1,000,000 units at $21.36), increasing direct ownership by 3% to 38,347,842 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/22/26 4:02:03 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    Director Attal Alain bought $259,577 worth of shares (12,000 units at $21.63), increasing direct ownership by 2% to 596,464 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/21/26 6:32:09 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $AACG
    $ABSI
    $ACY
    $APR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Longitude Capital Partners Ii, Llc sold $190,091 worth of shares (49,000 units at $3.88) (SEC Form 4)

    4 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Issuer)

    2/6/26 4:26:26 PM ET
    $RPID
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SVP Finance & Operations Carr Douglas sold $589 worth of shares (323 units at $1.82), decreasing direct ownership by 0.06% to 514,551 units (SEC Form 4)

    4 - Century Therapeutics, Inc. (0001850119) (Issuer)

    2/5/26 4:14:34 PM ET
    $IPSC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Innovation Officer Busch Andreas covered exercise/tax liability with 1,469 shares, decreasing direct ownership by 0.45% to 322,703 units (SEC Form 4)

    4 - Absci Corp (0001672688) (Issuer)

    2/4/26 4:53:14 PM ET
    $ABSI
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $AACG
    $ABSI
    $ACY
    $APR
    Financials

    Live finance-specific insights

    View All

    BILL Reports Second Quarter Fiscal Year 2026 Financial Results

    Q2 Core Revenue Increased 17% Year-Over-Year Q2 Total Revenue Increased 14% Year-Over-Year BILL (NYSE:BILL), the intelligent finance platform trusted by half a million businesses to manage, move and maximize their money, today announced financial results for the second fiscal quarter ended December 31, 2025. "We delivered a strong Q2, with a significant beat on revenue and profitability, and continued our track record of rapid innovation," said René Lacerte, BILL CEO and Founder. "With a leading position in a large market, strong brand recognition, and a differentiated platform and distribution ecosystem, we are leveraging our unique assets alongside AI to eliminate unnecessary wor

    2/5/26 4:01:00 PM ET
    $BILL
    EDP Services
    Technology

    BioCryst to Report Fourth Quarter 2025 Financial Results on February 26

    RESEARCH TRIANGLE PARK, N.C., Feb. 05, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its fourth quarter 2025 financial results on Thursday, February 26, 2026. BioCryst management will host a conference call and webcast at 8:30 a.m. ET that day to discuss the financial results and provide a corporate update. The live call may be accessed by dialing 1-844-481-2942 for domestic callers and 1-412-317-1866 for international callers. A live webcast and replay of the call will be available online in the investors section of the company website at www.biocryst.com. About BioCryst Pharmaceuticals BioCryst is a global biotechn

    2/5/26 7:01:00 AM ET
    $BCRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Take-Two Interactive Software, Inc. Reports Results for Fiscal Third Quarter 2026

    Company raises fiscal year 2026 outlook Fiscal third quarter Net Bookings were $1.76 billion, above Company's guidance range Net Bookings for fiscal year 2026 are now expected to range from $6.65 to $6.7 billion Take-Two Interactive Software, Inc. (NASDAQ:TTWO) today reported results for the third quarter of its fiscal year 2026, ended December 31, 2025. For further information, please see the third quarter fiscal 2026 results slide deck posted to the Company's investor relations website at take2games.com/ir. CEO Comments Strauss Zelnick, Chairman and CEO of Take-Two Interactive, stated: "Our outstanding third quarter results reflect outperformance from all of our labels, and we a

    2/3/26 4:05:00 PM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $AACG
    $ABSI
    $ACY
    $APR
    Leadership Updates

    Live Leadership Updates

    View All

    Pixelworks Appoints Sevan Brown to Lead Business Development for TrueCut Motion

    20-Year Media and Entertainment Executive to Drive Expanded Partnerships and Industry Adoption of TrueCut Motion™ Platform LOS ANGELES, Feb. 5, 2026 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ:PXLW) ("Pixelworks" or the "Company"), a provider of innovative cinematic and enhanced visualization solutions, today announced the appointment of Sevan Brown as Executive Vice President of Business Development. In the newly created role, Brown will lead the Company's enhanced focus on securing and growing global business partnerships for its TrueCut Motion platform with major Hollywood studios, international exhibitors and streaming service providers. Most recently, Brown served as Senior Vice President

    2/5/26 8:00:00 AM ET
    $PXLW
    Semiconductors
    Technology

    Breckenridge Distillery Appoints Romano Beverage for Distribution in Illinois

    BRECKENRIDGE, Colo., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand owned by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), has announced appointment of Romano Beverage, a respected partner, to manage distribution responsibilities within the state. Romano Beverage, a trusted leader in beverage distribution, is now overseeing Breckenridge Distillery's full spirits collection across Illinois—including its celebrated bourbon whiskey, whiskey, rum, vodka, gin, and newly launched Mountain Shot. Romano's strong presence in Illinois and dedication to exceptional service make them the perfect partner to help Breckenridge Distillery thr

    2/4/26 8:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH

    TAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced the hiring of Mimi Davis as President of MarpaiRx. Davis, a distinguished leader in the pharmacy services sector, will oversee the strategic expansion and operational scaling of Marpai's pharmacy benefit offerings. Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy—a former HillCour portfolio company—which was acquired by Knipper in 2020. With

    1/27/26 8:23:00 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    $AACG
    $ABSI
    $ACY
    $APR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    SEC Form SC 13G filed by Torrid Holdings Inc.

    SC 13G - Torrid Holdings Inc. (0001792781) (Subject)

    12/12/24 6:06:52 PM ET
    $CURV
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $AACG
    $ABSI
    $ACY
    $APR
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Immix Biopharma Inc. on Jun 5

    Recent insider purchases at Immix Biopharma Inc. have caught the attention of investors, with Morris Gabriel S leading the way by acquiring $5,973 worth of shares on June 5, 2024. This transaction involved 3,300 units at a price of $1.81 per share, increasing Gabriel's direct ownership by 1% to 283,334 units, as reported in SEC Form 4. This move indicates Gabriel's confidence in the company's potential and may be seen as a positive signal by market participants. Click here for more details. Looking back at previous insider transactions, we can identify a few interesting patterns. On May 15, 2024, Rachman Ilya M purchased $9,660 worth of shares, comprising 4,300 units at $2.25 per share, whi

    6/10/24 1:09:24 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care